Bioalert Technologies
About Bioalert Technologies
Bioalert Technologies develops a medical device intended to detect bacterial infections in real-time. The company's device is dedicated to the design and development of continuous infection monitoring systems for diabetic foot ulcer patients, enabling healthcare providers to make diagnosis and treatment decisions based on data metrics. It is based in Philadelphia, Pennsylvania.
Bioalert Technologies Headquarter Location
220 S 33rd St
Philadelphia, Pennsylvania, 19104,
United States
Expert Collections containing Bioalert Technologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Bioalert Technologies is included in 1 Expert Collection, including Diabetes.
Diabetes
1,750 items
Where is Bioalert Technologies's headquarters?
Bioalert Technologies's headquarters is located at 220 S 33rd St, Philadelphia.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.